EN HU

Csongrádi Éva

Csongrádi Éva

Teljes publikációs lista

2024
1.
Acharya, P. C., Alba, R., Krisanapan, P., Acharya, C. M., Suppadungsuk, S., Csongrádi, É., Mao, M. A., Craici, I. M., Miao, J., Thongprayoon, C., Cheungpasitporn, W.: AI-Driven Patient Education in Chronic Kidney Disease: Evaluating Chatbot Responses against Clinical Guidelines.
Diseases. 12 (8), 1-14, (cikkazonosító: 185), 2024.
2.
Pethő, Á. G., Tapolyai, M., Csongrádi, É., Orosz, P.: Management of chronic kidney disease: the current novel and forgotten therapies.
J. Clin. Transl. ENdocrinol. 36, 1-9, (cikkazonosító: 100354), 2024.
Folyóirat-mutatók:
Q3 Endocrinology (2023)
Q2 Endocrinology, Diabetes and Metabolism (2023)
3.
Abd Elaziz, M. A., Asmaa, M. G. E., Dina, Z. M. Z. A. H., Nohier, E. S. A. H., Csongrádi, É., Emad, H. H. M., Mohammed, A. G.: The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients.
Ren. Fail. 46 (1), 1-5, (cikkazonosító: 2346284), 2024.
Folyóirat-mutatók:
Q2 Critical Care and Intensive Care Medicine (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Nephrology (2023)
2023
4.
Fayed, A., Hammad, A. A., Abdulazim, D. O., Hammad, H., Amin, M., Elhadidy, S., Salem, M. M., ElAzim, I. M. A., Zsom, L., Csongrádi, É., Soliman, K. M., Sharaf El Din, U. A.: Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Ren. Fail. 45 (1), 2023.
Folyóirat-mutatók:
Q2 Critical Care and Intensive Care Medicine
Q2 Medicine (miscellaneous)
Q2 Nephrology
2019
5.
Csikai, E., Andrejkovics, M., Balajthy-Hidegh, B., Hofgárt, G., Kardos, L., Diószegi, Á., Rostás, R., Czuriga-Kovács, K. R., Csongrádi, É., Csiba, L.: Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension: a follow-up study.
Medicine (Baltimore). 98 (34), 1-9, 2019.
Folyóirat-mutatók:
Q2 Medicine (miscellaneous)
2017
6.
Csongrádi, É., Káplár, M., Nagy, B. J., Koch, C. A., Juhász, A., Bajnok, L., Varga, Z., Seres, I., Karányi, Z., Magyar, M. T., Oláh, L., Facskó, A., Kappelmayer, J., Paragh, G.: Adipokines as atherothrombotic risk factors in obese subjects: associations with haemostatic markers and common carotid wall thickness.
Nutr. Metab. Carbiovasc. Dis. 27 (6), 571-580, 2017.
Folyóirat-mutatók:
Q1 Cardiology and Cardiovascular Medicine
Q1 Endocrinology, Diabetes and Metabolism
Q1 Medicine (miscellaneous)
Q1 Nutrition and Dietetics
2015
7.
Farah Musa, A., Fülöp, T., Kokko, K., Kanyicska, B., Lewin, J. R., Csongrádi, É.: Cytomegalovirus colitis in a critically ill, dialysis-dependent, acute kidney injury patient without immunosuppressive therapy.
Clin. Nephrol. 84 (1), 44-49, 2015.
Folyóirat-mutatók:
Q2 Medicine (miscellaneous)
Q3 Nephrology
8.
Fülöp, T., Csongrádi, É., Lerant, A., Lewin, M., Lewin, J. R.: Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis.
J. Nephropathol. 4 (2), 2015.
Folyóirat-mutatók:
Q2 Nephrology
2014
9.
Csongrádi, É., Káplár, M., Nagy, B., Fülöp, T., Juhász, A., Bajnok, L., Varga, Z., Seres, I., Karányi, Z., Kappelmayer, J., Paragh, G.: Adipocitokinek thrombocyta aktivációs markerekkel való összefüggéseinek vizsgálata elhízott egyénekben.
Metabolizmus. 12, 1, 2014.
10.
Musa, A. F., Clarke, D. R., Gharaibeh, K. A., Tapolyai, M., Csongrádi, É., Pitman, K. T., Fülöp, T.: Targeted parathyroid gland reduction and long-term metabolic control of tertiary hyperparathyroidism.
Am. J. Kidney Dis. 63 (5), A46, 2014.
11.
Csongrádi, É., Shoemaker, M. M., Zsom, L., Wells, C., Lengvárszky, Z., Tapolyai, M., Fülöp, T.: The Efficacy of Intravenous versus Subcutaneous Recombinant Erythropoietin in Obese African-African Patients in a Southeast U.S. Dialysis Cohort.
Br. J. Med. Med. Res. 4 (1), 184-193, 2014.
2013
12.
Avusula, R., Shoemaker, M. M., Pathak, M. B., Csongrádi, É., Fülöp, T.: Bacterial Peritonitis Following Esophagogastroduodenoscopy in a Patient on Peritoneal Dialysis.
Br. J. Med. Med. Res. 3 (3), 784-789, 2013.
13.
Gharaibeh, K. A., Craig, M. J., Koch, C. A., Lerant, A., Fülöp, T., Csongrádi, É.: Desmopression is an effective adjunct treatment for reversing excessive hyponatremia overcorrection.
World J. Clin. Cases. 1 (5), 155-158, 2013.
14.
Fülöp, T., Iboaya, B. U., Avusula, R., Csongrádi, É., Juncos, L. A.: Recalcitrant hypoglycemia resolved with 2.5% dextrose containing replacement fluid during hemodiafiltration.
Ren. Fail. 35 (7), 1035-7, 2013.
Folyóirat-mutatók:
Q2 Critical Care and Intensive Care Medicine
Q2 Medicine (miscellaneous)
Q3 Nephrology
15.
Ferguson, L. M., Dreisbach, A. W., Csongrádi, É., Juncos, L. A., Fülöp, T.: Recurring Extracorporeal Circuit Clotting During Continuous Renal Replacement Therapy in Fungal Sepsis.
Am. J. Med. Sci. 345 (3), 256-258, 2013.
Folyóirat-mutatók:
Q2 Medicine (miscellaneous)
16.
Elmahi, N., Csongrádi, É., Kokko, K., Lewin, J. R., Davison, J., Fülöp, T.: Residual renal function in peritoneal dialysis with failed allograft and minimum immunosuppression.
World J. Transplant. 3 (2), 26-29, 2013.
17.
Agarwal, M., Csongrádi, É., Koch, C. A., Juncos, L. A., Echols, V., Tapolyai, M., Fülöp, T.: Severe Symptomatic Hypocalcemia after Denosumab Administration in an End-Stage Renal Disease Patient on Peritoneal Dialysis with Controlled Secondary Hyperparathyroidism.
Br. J. Med. Med. Res. 3 (4), 1398-1406, 2013.
18.
Fülöp, T., Tapolyai, M., Qureshi, N. A., Beemidi, V. R., Gharaibeh, K. A., Hamrahian, S. M., Szarvas, T., Kovesdy, C. P., Csongrádi, É.: The safety and efficacy of bedside removal of tunneled hemodialysis catheters by nephrology trainees.
Ren. Fail. 35 (9), 2013.
Folyóirat-mutatók:
Q2 Critical Care and Intensive Care Medicine
Q2 Medicine (miscellaneous)
Q3 Nephrology
2012
19.
Csongrádi, É., DoCarmo, J. M., Dubinion, J. H., Vera, T., Stec, D. E.: Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.
Int. J. Obes. (Lond). 36 (2), 244-253, 2012.
Folyóirat-mutatók:
D1 Endocrinology, Diabetes and Metabolism
D1 Medicine (miscellaneous)
D1 Nutrition and Dietetics
20.
Brar, M., Kokko, K., Csongrádi, É., Kanyicska, B., Fülöp, T.: Cytomegalovirus colitis in a critically ill, dialysis-dependent acute kidney injury patient without immunosupressive therapy.
AJKD. 59 (4), 39, 2012.
21.
Stec, D. E., Drummond, H. A., Gousette, M. U., Storm, M. V., Abraham, N. G., Csongrádi, É.: Expression of Heme Oxygenase-1 in Thick Ascending Loop of Henle Attenuates Angiotensin II-Dependent Hypertension.
J. Am. Soc. Nephrol. 23 (5), 834-841, 2012.
Folyóirat-mutatók:
D1 Medicine (miscellaneous)
D1 Nephrology
22.
Gharaibeh, K. A., Csongrádi, É., Shoemaker, M. M., Lerant, A., Tapolyai, M., Fülöp, T.: Pulmonary embolization with tunneled hemodialysis catheter-associated blood stream infection: the perils of systemic anticoagulation.
Nephrology reviews. 4 (2), 73-75, 2012.
23.
Csongrádi, É., Storm, M. V., Stec, D. E.: Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension.
Int. J. Hypertens. 2012, Article ID 497213, 2012.
Folyóirat-mutatók:
Q2 Internal Medicine
24.
Csongrádi, É., Juncos, L. A., Drummond, H. A., Vera, T., Stec, D. E.: Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney?.
Curr. Pharm. Biotechnol. 13 (6), 819-826, 2012.
Folyóirat-mutatók:
Q1 Biotechnology
Q1 Pharmaceutical Science
25.
Hamrahian, S. M., Pitman, K. T., Csongrádi, É., Bain, J. H., Kanyicska, B., Fülöp, T.: Symmetrical craniofacial hypertrophy in patients with tertiary hyperparathyroidism and high-dose cinacalcet exposure.
Hemodial Int. 16 (4), 571-576, 2012.
Folyóirat-mutatók:
Q2 Hematology
Q2 Nephrology
DEENK Debreceni Egyetem
© 2012 Debreceni Egyetem